Eisai
4523.T
#2559
Rank
โ‚น670.29 B
Marketcap
โ‚น2,376
Share price
2.13%
Change (1 day)
3.28%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น82.29. an increase over its 2024 EPS that were of โ‚น92.77.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น103.7611.85%
2024โ‚น92.77-32.63%
2023โ‚น137.705.52%
2022โ‚น130.50-74.01%
2021โ‚น502.06-66.58%
2020โ‚น1,50298.24%
2019โ‚น757.6917.01%
2018โ‚น647.5437.78%
2017โ‚น469.99-27.62%
2016โ‚น649.3635.33%
2015โ‚น479.83-2.82%
2014โ‚น493.77-27.66%
2013โ‚น682.61-27.49%
2012โ‚น941.44-12.67%
2011โ‚น1,07888.08%
2010โ‚น573.20-11.06%
2009โ‚น644.50-390.15%
2008-โ‚น222.13-127.78%
2007โ‚น799.7011.78%
2006โ‚น715.444.38%
2005โ‚น685.457.4%
2004โ‚น638.2543.03%
2003โ‚น446.2525.09%
2002โ‚น356.7352.67%
2001โ‚น233.6669.76%
2000โ‚น137.64